Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in New Onset Diabetes After Transplantation
NCT00980356Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vildagliptin in post-transplant diabetes mellitus (PTDM), sponsored by Medical University of Vienna. Started Sep 2009; status: completed.
02
Drugs
vildagliptin
03
Conditions
post-transplant diabetes mellitus (PTDM)
Beyond the preview
Go deeper on NCT00980356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980356.